Founders Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Founders Capital Management, LLC

$571 Million
Q3 2024

A detailed history of Founders Capital Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Founders Capital Management, LLC holds 7,732 shares of REGN stock, worth $5.72 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares

7,732

Previous 7,785 0.68%

Holding current value

$5.72 Million

Previous $8.18 Million 0.66%

% of portfolio

1.42%

Previous 1.48%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$1024.09 - $1201.76 $54,276 - $63,693	-53 Reduced 0.68%	7,732 $8.13 Million
Q2 2024 Jul 17, 2024	SELL	$883.2 - $1071.19 $47,692 - $57,844	-54 Reduced 0.69%	7,785 $8.18 Million
Q4 2023 Jan 23, 2024	SELL	$775.18 - $881.7 $75,967 - $86,406	-98 Reduced 1.23%	7,839 $6.88 Million
Q3 2023 Oct 24, 2023	SELL	$692.45 - $844.37 $65,782 - $80,215	-95 Reduced 1.18%	7,937 $6.53 Million
Q2 2023 Jul 26, 2023	SELL	$700.03 - $830.35 $95,204 - $112,927	-136 Reduced 1.67%	8,032 $5.77 Million
Q1 2023 Apr 18, 2023	SELL	$680.49 - $826.97 $83,019 - $100,890	-122 Reduced 1.47%	8,168 $6.71 Million
Q4 2022 Jan 20, 2023	SELL	$705.89 - $766.39 $151,766 - $164,773	-215 Reduced 2.53%	8,290 $0
Q3 2022 Oct 21, 2022	SELL	$573.97 - $724.32 $60,840 - $76,777	-106 Reduced 1.23%	8,505 $5.86 Million
Q2 2022 Jul 25, 2022	BUY	$548.35 - $738.84 $13,160 - $17,732	24 Added 0.28%	8,611 $5.09 Million
Q1 2022 May 03, 2022	BUY	$595.12 - $698.43 $49,990 - $58,668	84 Added 0.99%	8,587 $6 Million
Q4 2021 Jan 27, 2022	SELL	$543.48 - $670.97 $160,870 - $198,607	-296 Reduced 3.36%	8,503 $5.37 Million
Q3 2021 Oct 21, 2021	SELL	$574.03 - $680.96 $70,031 - $83,077	-122 Reduced 1.37%	8,799 $5.33 Million
Q2 2021 Jul 15, 2021	BUY	$472.8 - $558.54 $2.36 Million - $2.79 Million	5,001 Added 127.58%	8,921 $4.98 Million
Q1 2021 Apr 12, 2021	BUY	$446.73 - $548.2 $1.49 Million - $1.83 Million	3,343 Added 579.38%	3,920 $1.86 Million
Q3 2018 Oct 11, 2018	BUY	$351.14 - $408.51 $202,607 - $235,710	577 New	577 $226,000
Q1 2018 Apr 04, 2018	SELL	$315.82 - $393.78 $182,228 - $227,211	-577 Closed	0 $0
Q3 2017 Oct 24, 2017	SELL	$431.38 - $504.0 $43,138 - $50,400	-100 Reduced 14.77%	577 $258,000
Q3 2017 Oct 16, 2017	BUY	$431.38 - $504.0 $292,044 - $341,208	677	677 $258,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management, LLC with notifications on news.

Account

Founders Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History